• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsAC Immune SA
    Picture of AC Immune SA logo

    ACIU — AC Immune SA News Story

    $2.560.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapMomentum Trap
    • Market Cap
      $260.54m
    • Enterprise Value
      $173.47m
    • Revenue
      CH₣3.57m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ACIU Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ACIU Dividends
    All News

    NASDAQ RESUMED AT 07:30 AM

    Picture of AC Immune SA logoAC Immune SA
    11/12/2025 12:30
    NASDAQ RESUMED  ACIU.O  AT 07:30 AM
    

    Recent news on AC Immune SA

    See all news
    • Brief: Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease

      11/06/2026 12:02
    • AC Immune Q1 net loss narrows on lower expenses

      30/04/2026 12:33
    • Brief: AC Immune Announces Amendment To Morphomer ® Tau License And Collaboration Agreement With Lilly

      07/04/2026 12:13
    • U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture

      19/03/2026 17:59
    • U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture

      19/03/2026 15:51

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.